Siemens expands AI-driven pharma software portfolio, integrating Dotmatics’ platform to connect drug research, development, ...

Dotmatics is Using a New AI-Powered “Lab-in-a-Loop” to Help Big Pharma Bring Therapies to Market – Faster & Cheaper One year ago, the AI hype tsunami hit the world, with promises that LLMs ...

Siemens has agreed to acquire Dotmatics for $5.1 billion, a combination the companies said would use artificial intelligence to speed up development cycles and help make breakthroughs in the life ...

Siemens AG said on Wednesday it will acquire U.S.-based Dotmatics for $5.1 billion from private equity firm Insight Partners to strengthen its Life Sciences portfolio.

Dotmatics®, a leading provider of scientific software that provides end-to-end solutions to connect science, data, and decision making for life sciences R&D, today announced it has signed a ...

Boston-based Dotmatics helping scientists make better drugs using AI 02:35. BOSTON – Getting a new drug to market in the U.S. has perhaps never been more difficult.

Dotmatics centralizes data from disparate sources — applications, databases, and lab instruments — enabling AI algorithms to analyze this information at an unprecedented scale.

BOSTON--(BUSINESS WIRE)--Dotmatics was today announced as the formal name and brand for the combined entities of Insightful Science and Dotmatics.As the Insightful Science brand is retired, the ...

Dotmatics, a leader in R&D scientific software connecting science, data, and decision-making, today announced the successful acquisition of EasyPanel, a high-growth company specializing in flow ...

As Dotmatics continues to innovate, the company aims to push the boundaries of drug discovery through integrated bioinformatics and AI-driven research. Daily insights on business use cases with VB ...

Siemens SIE-0.21%decrease; red down pointing triangle has agreed to acquire Dotmatics for $5.1 billion, a combination the companies said would use artificial intelligence to speed up development ...